THC clinical trials at UCSD
2 in progress, 0 open to eligible people
Dose-Ranging Trial of Inhaled Cannabis for Acute Migraine Treatment
Sorry, accepting new patients by invitation only
This pilot crossover study will evaluate 3 different potencies of inhaled cannabis (2.5%, 5%, and 10%) and inhaled placebo cannabis for the acute treatment of migraine.
La Jolla, California
Effects of Cannabidiol and Tetrahydrocannabinol on Microbiome and Neuroinflammation in HIV
Sorry, not yet accepting patients
This study has the potential to contribute to a more complete understanding of the independent and combined effects of cannabis use and HIV on the brain and on inflammation. Such knowledge may inform future strategies for treating brain disease and inflammation. Participants will be randomly assigned to one of two groups, both of which will receive the same treatment in a different order over a period of about 6 weeks. The visits include physical examinations, blood tests, and other procedures designed to monitor subject safety and measure the effects of the study drug.
San Diego, California
Our lead scientists for THC research studies include Ronald J Ellis, MD, PhD Nathaniel M Schuster, MD.